Stock Signal Information
Signal
Analyst Coverage Resumed Stock
Report Date: 05-05-2022
Symbol: AUPH - Aurinia Pharmaceuticals Inc.
Sector: Healthcare
Industry: Biotechnology
Analyst Coverage Resumed: AUPH rating Overweight by Cantor Fitzgerald
Price Target: $34>>25
Company Contact
Aurinia Pharmaceuticals Inc. (AUPH)
1203-4464 Markham St
Victoria, BRITISH COLUMBIA V8Z 7X8
Phone: 12507084272
Website: http://www.auriniapharma.com
CEO: Mr. Peter Greenleaf
Company Profile
Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops and commercializes therapies to treat various diseases in the United States and China. It is involved in developing voclosporin, an investigational drug for the treatment of lupus nephritis, dry eye syndrome, and focal segmental glomerulosclerosis. The company is headquartered in Victoria, Canada.
best stock signal service providers, stock option trading signals, daily stock signals, best stock signal alert software
About Top Stock Signals
Good stock signals have been found on this server. That is all we know.
+1 (407) 559-7228
A.I. in Stock and Option Trading FAQs
How can AI help with portfolio optimization?What are the limitations of AI in stock and option trading?How do I implement AI in my existing trading infrastructure?Is AI more suitable for quantitative or discretionary trading?What are some popular AI tools for options trading?A.I. in Stock and Option Trading FAQsStock Trading FAQsOptions Trading FAQs